Revvity (RVTY) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

RVTY Stock Forecast


Revvity stock forecast is as follows: an average price target of $123.83 (represents a 1.48% upside from RVTY’s last price of $122.03) and a rating consensus of 'Hold', based on 8 wall street analysts offering a 1-year stock forecast.

RVTY Price Target


The average price target for Revvity (RVTY) is $123.83 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $135.00 to $110.00. This represents a potential 1.48% upside from RVTY's last price of $122.03.

RVTY Analyst Ratings


Hold

According to 8 Wall Street analysts, Revvity's rating consensus is 'Hold'. The analyst rating breakdown for RVTY stock is 0 'Strong Buy' (0.00%), 3 'Buy' (37.50%), 5 'Hold' (62.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Revvity Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 30, 2024Derik de BruinBank of America Securities$127.00$125.591.12%4.07%
Jul 29, 2024Tycho PetersonJefferies$125.00$125.29-0.23%2.43%
Jul 29, 2024Daniel AriasStifel Nicolaus$110.00$120.16-8.46%-9.86%
Jul 29, 2024Patrick DonnellyCitigroup$135.00$120.1612.35%10.63%
Jul 29, 2024Vijay KumarEvercore ISI$126.00$120.164.86%3.25%
Apr 29, 2024Dan LeonardUBS$120.00$105.0214.26%-1.66%
Row per page
Go to

The latest Revvity stock forecast, released on Jul 30, 2024 by Derik de Bruin from Bank of America Securities, set a price target of $127.00, which represents a 1.12% increase from the stock price at the time of the forecast ($125.59), and a 4.07% increase from RVTY last price ($122.03).

Revvity Price Target by Period


1M3M12M
# Anlaysts-56
Avg Price Target-$124.60$123.83
Last Closing Price$122.03$122.03$122.03
Upside/Downside-100.00%2.11%1.48%

In the current month, the average price target of Revvity stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Revvity's last price of $122.03. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 27, 2024Wells Fargo-Equal-WeightInitialise
Jul 30, 2024Cowen & Co.BuyBuyHold
Jul 30, 2024BarclaysEqual-WeightEqual-WeightHold
Jul 30, 2024Bank of America SecuritiesNeutralNeutralHold
Jul 29, 2024JefferiesHoldHoldHold
Jul 29, 2024Evercore ISIOutperformOutperformHold
Jul 29, 2024CitigroupBuyBuyHold
Apr 30, 2024Cowen & Co.BuyBuyHold
Apr 29, 2024UBSNeutralNeutralHold
Row per page
Go to

Revvity's last stock rating was published by Wells Fargo on Aug 27, 2024. The company Initialise its RVTY rating from "null" to "Equal-Weight".

Revvity Financial Forecast


Revvity Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue---------------$674.87M$741.21M$711.80M$1.23B$1.26B$1.36B$1.17B$1.23B$1.31B$1.35B$964.02M$811.72M$652.40M$805.50M$706.92M
Avg Forecast$856.02M$781.77M$786.48M$736.41M$798.78M$724.24M$737.09M$695.91M$754.10M$679.99M$690.33M$647.25M$677.13M$695.40M$708.38M$678.90M$1.03B$1.02B$1.20B$1.19B$1.27B$1.04B$1.12B$1.21B$1.23B$840.15M$722.01M$649.26M$801.08M$721.38M
High Forecast$866.26M$791.11M$795.88M$745.22M$808.33M$732.90M$745.90M$704.23M$763.12M$683.65M$698.58M$654.99M$682.85M$706.09M$716.85M$687.02M$1.04B$1.03B$1.21B$1.20B$1.28B$1.05B$1.13B$1.22B$1.24B$847.56M$728.38M$654.99M$808.14M$727.75M
Low Forecast$846.11M$772.72M$777.37M$727.89M$789.53M$715.86M$728.55M$687.86M$745.37M$673.95M$682.34M$639.76M$669.72M$685.27M$700.18M$671.04M$1.02B$1.01B$1.19B$1.18B$1.26B$1.03B$1.11B$1.20B$1.21B$831.67M$714.72M$642.71M$792.99M$714.10M
# Analysts107558544811536129955556666999955
Surprise %---------------0.99%0.72%0.70%1.02%1.06%1.07%1.12%1.09%1.08%1.11%1.15%1.12%1.00%1.01%0.98%

Revvity's average Quarter revenue forecast for Jun 23 based on 9 analysts is $708.38M, with a low forecast of $700.18M, and a high forecast of $716.85M. RVTY's average Quarter revenue forecast represents a 4.97% increase compared to the company's last Quarter revenue of $674.87M (Mar 23).

Revvity EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts107558544811536129955556666999955
EBITDA---------------$158.42M$266.62M$220.69M$380.02M$391.55M$465.46M$313.89M$414.87M$551.24M$546.42M$312.35M$236.86M$114.97M$170.25M$147.27M
Avg Forecast$255.69M$233.52M$234.92M$219.97M$238.60M$216.33M$220.17M$207.87M$225.25M$203.11M$206.20M$193.33M$202.26M$207.72M$211.59M$202.79M$307.32M$305.05M$359.56M$355.16M$380.39M$310.97M$335.36M$361.69M$365.93M$250.95M$215.67M$193.94M$239.28M$215.48M
High Forecast$258.75M$236.31M$237.73M$222.60M$241.45M$218.92M$222.80M$210.36M$227.94M$204.21M$208.67M$195.65M$203.97M$210.91M$214.12M$205.21M$310.99M$308.70M$362.73M$358.29M$383.74M$313.72M$338.32M$364.88M$369.16M$253.17M$217.57M$195.65M$241.39M$217.38M
Low Forecast$252.73M$230.81M$232.20M$217.42M$235.83M$213.83M$217.62M$205.46M$222.64M$201.31M$203.81M$191.10M$200.05M$204.69M$209.15M$200.44M$303.76M$301.52M$355.93M$351.58M$376.55M$307.83M$331.97M$358.04M$362.24M$248.42M$213.49M$191.98M$236.87M$213.30M
Surprise %---------------0.78%0.87%0.72%1.06%1.10%1.22%1.01%1.24%1.52%1.49%1.24%1.10%0.59%0.71%0.68%

9 analysts predict RVTY's average Quarter EBITDA for Jun 23 to be $211.59M, with a high of $214.12M and a low of $209.15M. This is 33.57% upper than Revvity's previous annual EBITDA (Mar 23) of $158.42M.

Revvity Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts107558544811536129955556666999955
Net Income---------------$24.84M$107.50M$85.35M$179.21M$176.96M$179.18M$127.74M$245.93M$379.31M$380.36M$176.70M$137.16M$33.66M$64.50M$58.56M
Avg Forecast$202.12M$175.53M$176.69M$156.08M$186.11M$154.48M$158.87M$138.92M$176.80M$139.12M$138.52M$116.38M$143.81M$147.39M$146.79M$123.31M$202.35M$177.82M$248.69M$261.16M$277.54M$214.86M$300.90M$381.43M$371.86M$185.64M$104.51M$68.78M$163.69M$124.55M
High Forecast$205.26M$178.26M$179.43M$158.50M$189.00M$156.88M$161.34M$141.07M$179.55M$141.29M$140.68M$118.19M$147.56M$154.82M$149.07M$125.23M$205.50M$180.59M$251.54M$264.15M$280.72M$217.32M$304.35M$385.81M$376.13M$187.77M$105.71M$69.57M$165.57M$125.98M
Low Forecast$199.08M$172.89M$174.03M$153.73M$183.31M$152.16M$156.47M$136.82M$174.14M$137.89M$136.44M$114.63M$142.56M$142.44M$144.58M$121.45M$199.31M$175.15M$245.43M$257.73M$273.90M$212.04M$296.96M$376.43M$366.98M$183.20M$103.14M$67.88M$161.54M$122.91M
Surprise %---------------0.20%0.53%0.48%0.72%0.68%0.65%0.59%0.82%0.99%1.02%0.95%1.31%0.49%0.39%0.47%

Revvity's average Quarter net income forecast for Jun 23 is $146.79M, with a range of $144.58M to $149.07M. RVTY's average Quarter net income forecast represents a 490.83% increase compared to the company's last Quarter net income of $24.84M (Mar 23).

Revvity SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts107558544811536129955556666999955
SG&A---------------$248.56M$244.32M$239.97M$330.02M$334.39M$355.25M$339.05M$281.82M$251.41M$263.05M$225.25M$221.03M$208.57M$210.74M$204.17M
Avg Forecast$225.36M$205.81M$207.05M$193.87M$210.29M$190.67M$194.05M$183.21M$198.53M$179.02M$181.74M$170.40M$178.26M$183.07M$186.49M$178.73M$270.85M$268.86M$316.90M$313.02M$335.26M$274.08M$295.57M$318.77M$322.52M$221.18M$190.08M$170.93M$210.89M$189.91M
High Forecast$228.05M$208.27M$209.53M$196.19M$212.80M$192.95M$196.37M$185.40M$200.90M$179.98M$183.91M$172.43M$179.77M$185.89M$188.72M$180.87M$274.09M$272.07M$319.70M$315.78M$338.21M$276.49M$298.18M$321.59M$325.36M$223.13M$191.75M$172.43M$212.75M$191.59M
Low Forecast$222.75M$203.43M$204.65M$191.63M$207.85M$188.46M$191.80M$181.09M$196.23M$177.42M$179.63M$168.42M$176.31M$180.40M$184.33M$176.66M$267.72M$265.75M$313.70M$309.86M$331.87M$271.31M$292.59M$315.56M$319.26M$218.95M$188.16M$169.20M$208.77M$188.00M
Surprise %---------------1.39%0.90%0.89%1.04%1.07%1.06%1.24%0.95%0.79%0.82%1.02%1.16%1.22%1.00%1.08%

Revvity's average Quarter SG&A projection for Jun 23 is $186.49M, based on 9 Wall Street analysts, with a range of $184.33M to $188.72M. The forecast indicates a -24.97% fall compared to RVTY last annual SG&A of $248.56M (Mar 23).

Revvity EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts107558544811536129955556666999955
EPS---------------$0.20$0.85$0.68$1.42$1.40$1.42$1.12$2.20$3.39$3.40$1.58$1.23$0.30$0.58$0.53
Avg Forecast$1.64$1.42$1.43$1.26$1.51$1.25$1.29$1.13$1.43$1.13$1.12$0.94$1.16$1.19$1.19$1.00$1.64$1.44$2.01$2.12$2.25$1.74$2.44$3.09$3.01$1.50$0.85$0.56$1.33$1.01
High Forecast$1.66$1.44$1.45$1.28$1.53$1.27$1.31$1.14$1.45$1.14$1.14$0.96$1.20$1.25$1.21$1.01$1.66$1.46$2.04$2.14$2.27$1.76$2.46$3.12$3.05$1.52$0.86$0.56$1.34$1.02
Low Forecast$1.61$1.40$1.41$1.24$1.48$1.23$1.27$1.11$1.41$1.12$1.10$0.93$1.15$1.15$1.17$0.98$1.61$1.42$1.99$2.09$2.22$1.72$2.40$3.05$2.97$1.48$0.84$0.55$1.31$1.00
Surprise %---------------0.20%0.52%0.47%0.71%0.66%0.63%0.64%0.90%1.10%1.13%1.05%1.45%0.54%0.44%0.53%

According to 9 Wall Street analysts, Revvity's projected average Quarter EPS for Jun 23 is $1.19, with a low estimate of $1.17 and a high estimate of $1.21. This represents a 494.40% increase compared to RVTY previous annual EPS of $0.20 (Mar 23).

Revvity Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ACRSAclaris Therapeutics$1.18$25.002018.64%Buy
CRLCharles River Laboratories$198.61$324.4663.37%Buy
LHLaboratory Corporation of America$221.13$287.0029.79%Buy
MEDPMedpace$351.67$444.2026.31%Buy
QGENQiagen$46.36$52.3712.96%Buy
IQVIQVIA$238.70$269.4312.87%Buy
NEOGNeogen$16.13$17.508.49%Buy
AAgilent$137.31$144.905.53%Buy
ICLRICON Public Limited Company$300.00$307.632.54%Buy
RVTYRevvity$122.03$123.831.48%Hold
WATWaters$325.86$325.00-0.26%Buy
MTDMettler-Toledo$1.38K$1.36K-1.35%Hold
IDXXIDEXX Laboratories$500.55$479.75-4.16%Buy
TWSTTwist Bioscience$46.95$41.20-12.25%Buy
OLKOlink AB (publ)$26.08$21.50-17.56%Hold

RVTY Forecast FAQ


No, according to 8 Wall Street analysts, Revvity (RVTY) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 37.50% of RVTY's total ratings.

Revvity (RVTY) average price target is $123.83 with a range of $110 to $135, implying a 1.48% from its last price of $122.03. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for RVTY stock, the company can go up by 1.48% (from the last price of $122.03 to the average price target of $123.83), up by 10.63% based on the highest stock price target, and down by -9.86% based on the lowest stock price target.

RVTY's average twelve months analyst stock price target of $123.83 does not support the claim that Revvity can reach $200 in the near future.

Revvity's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.96B (high $2.99B, low $2.92B), average EBITDA is $882.97M (high $893.53M, low $872.75M), average net income is $638.37M (high $648.3M, low $628.76M), average SG&A $778.21M (high $787.51M, low $769.2M), and average EPS is $5.17 (high $5.25, low $5.09). RVTY's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.16B (high $3.2B, low $3.12B), average EBITDA is $944.1M (high $955.39M, low $933.17M), average net income is $710.42M (high $721.46M, low $699.73M), average SG&A $832.09M (high $842.04M, low $822.45M), and average EPS is $5.75 (high $5.84, low $5.67).

Based on Revvity's last annual report (Dec 2022), the company's revenue was $3.31B, which missed the average analysts forecast of $4.44B by -25.46%. Apple's EBITDA was $1.2B, missing the average prediction of $1.33B by -9.69%. The company's net income was $579.18M, missing the average estimation of $890.02M by -34.93%. Apple's SG&A was $1.03B, missing the average forecast of $1.17B by -12.32%. Lastly, the company's EPS was $4.51, missing the average prediction of $7.21 by -37.43%. In terms of the last quarterly report (Mar 2023), Revvity's revenue was $674.86M, missing the average analysts' forecast of $678.9M by -0.59%. The company's EBITDA was $158.42M, missing the average prediction of $202.79M by -21.88%. Revvity's net income was $24.84M, missing the average estimation of $123.31M by -79.85%. The company's SG&A was $248.56M, beating the average forecast of $178.73M by 39.07%. Lastly, the company's EPS was $0.2, missing the average prediction of $0.999 by -79.97%